Sector
PharmaceuticalsOpen
₹173.2Prev. Close
₹177.3Turnover(Lac.)
₹86.87Day's High
₹177Day's Low
₹164.9552 Week's High
₹235.152 Week's Low
₹88Book Value
₹36.2Face Value
₹10Mkt Cap (₹ Cr.)
543.43P/E
21.92EPS
8.09Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 31.36 | 6.27 | 6.27 | 6.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 58.32 | 67.2 | 59.42 | 48.27 |
Net Worth | 89.68 | 73.47 | 65.69 | 54.54 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 73.58 | 55.85 | 49.02 | 45.23 |
yoy growth (%) | 31.75 | 13.91 | 8.37 | 17.71 |
Raw materials | -35.14 | -27.92 | -30.9 | -23.68 |
As % of sales | 47.75 | 50 | 63.04 | 52.36 |
Employee costs | -7.23 | -5.93 | -5.89 | -5.15 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 15.99 | 9.44 | 3.11 | 7.25 |
Depreciation | -2 | -1.98 | -1.55 | -1.34 |
Tax paid | -3.92 | -2.2 | -0.77 | -2.54 |
Working capital | -2.98 | 1.78 | 1.37 | 0.76 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 31.75 | 13.91 | 8.37 | 17.71 |
Op profit growth | 53.18 | 128.88 | -38.93 | 10.02 |
EBIT growth | 61.46 | 169.63 | -48.39 | 11.56 |
Net profit growth | 66.72 | 208.76 | -50.21 | 10.95 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Dhirajbhai Karsandas Patel
Whole-time Director
D H Patel
Independent Non Exe. Director
Bharatbhai M Shah
Independent Non Exe. Director
Ketanbhai C Patel
Independent Non Exe. Director
Thakarshibhai M Patel
Non-Exec & Non-Independent Dir
Alpaben Alpeshbhai Patel
Whole-time Director
Ankur D Patel
Independent Non Exe. Director
Shailesh P Patel
Independent Non Exe. Director
Vipulkumar Vitthalbhai Patel
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Vikram Thermo (India) Ltd
Summary
Vikram Thermo (India) Limited is one of the fastest growing Pharmaceutical company. The Company is a manufacturer, marketer & exporter of various pharmaceutical excipients, who provides complete solution in Film Coating / Enteric coating & Sustain Release / Control Release formulations to pharma industry. Its prestigious brand Drugcoat is one of the common name in many pharmaceutical industries.The Company has 2 dedicated plants for manufacturing of Aromatic Chemical and Pharma Polymer, located at Dhanot and Indrad in Gujarat. Unit - I is a well-equipped dedicated manufacturing facility with high end latest technology for pharma and cosmetic polymers having capacity of 6000 TPA. Unit - II operate as a technologically advanced manufacturing unit with modern technology spread over 13,000 sq.mt with a capacity of 4000 TPA.The companys products range include methacrylic acid copolymers, such as Drugcoat L 100, Drugcoat L 12.5, Drugcoat L 100-55, Drugcoat L 100-55D, Drugcoat RL 100, Drugcoat RS 12.5 and Drugcoat L 30D; Pharma Polymers, such as Drugpol 940/934, and heat transfer fluid, including Diphenyl Oxide. The Companys product Drugcoat is used in enteric coating, film coating, transparent coating, sustained release, moisture barrier coating and taste masking; Drugpol is used as thickener, suspending agent, topical application and stabilizer, and Diphenyl Oxide is used in heat transfer fluid, reaction solvent in the manufacture of active pharmaceutical ingredient (API) and as
Read More
The Vikram Thermo (India) Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹173.3 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vikram Thermo (India) Ltd is ₹543.43 Cr. as of 22 Jul ‘24
The PE and PB ratios of Vikram Thermo (India) Ltd is 21.92 and 4.90 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Vikram Thermo (India) Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vikram Thermo (India) Ltd is ₹88 and ₹235.1 as of 22 Jul ‘24
Vikram Thermo (India) Ltd's CAGR for 5 Years at 59.05%, 3 Years at 53.78%, 1 Year at 93.73%, 6 Month at 16.53%, 3 Month at 20.57% and 1 Month at 0.11%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.